Skip to content

Author

Hussain A. M. Khan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Abstract 10888: Clinical Outcomes of Novel Aldosterone Synthase Inhibitors (Lorundrostat and Baxdrostat) in Low and High Dose in Uncontrolled Hypertension: A Systematic Review and Meta-Analysis of RCTs

Background: Despite the availability of antihypertensive therapies, uncontrolled and resistant hypertension remains common, possibly driven by inappropriate aldosterone activity. Novel aldosterone synthase inhibitors (ASIs) such as Lorundrostat and Baxdrostat selectively inhibit CYP11B2, offering to reduce aldostero...

Hussain Khan, Anfal Khan, Mohammad Idrees et al. · 0 citations
Review Open access Sep 2026

Dual antiplatelet therapy duration after percutaneous coronary intervention with contemporary drug-eluting stents: A systematic review and network meta-analysis of randomized trials

Shorter DAPT durations (1 & 3 months) were associated with reduced bleeding without evidence of increased ischemic risk compared with the conventional 12-month strategy, suggesting it may represent a pragmatic threshold for DAPT abbreviation.

Admire Hlupeni, Mehran Jalilzadehbinazar, R. J. Liceralde et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.